Amphenol’s CEO Cash-Out Collides With a Record Order Book — Here’s What the Split Noise Misses

The most telling detail in Amphenol’s recent insider filings isn’t the dollar figure attached to CEO Richard Adam Norwitt’s June transactions — it’s the timing. Six separate disclosures totaling $126.3 million, comprising four option exercises and two share sales, landed just weeks before the company’s 2-for-1 stock split took effect on September 2. That places the chief executive’s moves squarely in a window when the shares were hovering near their all-time highs, a juxtaposition that has left investors parsing whether the sell-down carries any signal at all.

What complicates any bearish reading is the behavior of the institutional crowd during the same stretch. JPMorgan Chase & Co. established a fresh position of roughly 39.2 million shares, valued at an estimated $6.91 billion, while Capital International Investors, Sixth Street Partners and Price T Rowe Associates all added meaningfully to their holdings. FMR LLC, by contrast, trimmed its stake by about 8.9 million shares, a reduction of 11.2 percent. That divergence among heavyweight investors suggests the CEO’s transactions — which are subject to mandatory disclosure in the United States but often reflect personal liquidity needs or tax planning rather than a changed outlook — don’t align neatly with any single institutional thesis.

The share price itself tells a story of consolidation rather than conviction either way. Amphenol closed Friday at €71.67, up 1.5 percent on the day and 5.3 percent for the week, yet still 4.8 percent below its level a month earlier. The stock sits 8.3 percent beneath its 52-week high of €78.13, though it has climbed 54 percent from the year’s low touched on September 5, 2025. Since trading began on a split-adjusted basis, the shares have added 1.5 percent, and they currently hold 2.3 percent above their 50-day moving average — evidence of an intact short-term uptrend that has yet to produce fresh peaks.

Should investors sell immediately? Or is it worth buying Amphenol?

The real foundation beneath the price action dates back to late July, when Amphenol reported second-quarter results that beat expectations on both the top and bottom lines. Revenue surged 55 percent to $8.8 billion, while adjusted earnings per share climbed 67 percent to $1.35. More striking was the order intake: $10.7 billion, a record figure that translated into a book-to-bill ratio of 1.23-to-1 and underscored how deeply the AI infrastructure buildout continues to penetrate the company’s end markets.

Management guided third-quarter revenue to a range of $9.3 billion to $9.4 billion, implying year-over-year growth of 50 to 52 percent. The IT/Datacom segment, which generated 43 percent of second-quarter sales and grew organically by 63 percent, remains the primary engine — with AI-related products accounting for nearly all of that expansion. The integration of CommScope’s connectivity and cable solutions business, acquired earlier this year, has broadened the product lineup in data-intensive applications, and Amphenol recently raised its expected 2026 revenue contribution from that unit to $4.6 billion.

For all the attention lavished on the split mechanics and the insider disclosures, the technical adjustment has been processed and the selling appears to reflect positioning rather than pessimism. The next genuine test arrives with third-quarter results, when investors will see whether the guided revenue range materializes and whether the record backlog translates into durable growth. Until then, the order book — not the option exercises — remains the metric that matters.